Design Therapeutics, Inc. (DSGN)

NMS – Real Time Price. Currency in USD

14.64

+0.02 (0.14%)

Market open: Aug 12, 2026, 2:10 PM EDT

14.33

-0.29 (-1.98%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

Cost of goods sold

-622K

-596K

-537K

-466K

Gross Profit

-622K

-596K

-537K

-466K

Operating expenses (excl. COGS)

-79M

-62M

-78M

-67M

Operating Income

-79M

-62M

-78M

-68M

Non-operating income, total

10M

13M

11M

Pretax income

-70M

-50M

-67M

-63M

Equity in earnings

Taxes

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-70M

-50M

-67M

-63M

Discontinued operations

Net income

-70M

-50M

-67M

-63M

Dilution adjustment

Preferred dividends

Design Therapeutics, Inc. (DSGN)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Design Therapeutics, Inc. (DSGN)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Design Therapeutics, Inc. (DSGN)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Design Therapeutics, Inc. (DSGN)

Income Statement (Annual)

Income Statement (Annual)